Evidence map›Paper›PMID 28489917›Full record

ArticlePLoS pathogens2017

Mucosal fluid glycoprotein DMBT1 suppresses twitching motility and virulence of the opportunistic pathogen Pseudomonas aeruginosa.

Jianfang Li, Matteo M E Metruccio, David J Evans, Suzanne M J Fleiszig

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. ThemBio · 2025
    Article
  7. Article
  8. Review
  9. Contact Lens Wear Alters Transcriptional Responses tobioRxiv : the preprint server for biology · 2024
    Article
  10. Article
  11. Article
  12. Nerve-associated transient receptor potential ion channels can contribute to intrinsic resistance to bacterial adhesion in vivo.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2021
    Article
  13. Article
  14. Mucolytic bacteria: prevalence in various pathological diseases.World journal of microbiology & biotechnology · 2021
    Review
  15. Article
  16. American Academy of Optometry Microbial Keratitis Think Tank.Optometry and vision science : official publication of the American Academy of Optometry · 2021
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jianfang LiSchool of Optometry, University of California, Berkeley, California, United States of America.ORCID http://orcid.org/0000-0002-6085-7474
Matteo M E MetruccioSchool of Optometry, University of California, Berkeley, California, United States of America.ORCID http://orcid.org/0000-0002-2456-2652
David J EvansSchool of Optometry, University of California, Berkeley, California, United States of America.
Suzanne M J FleiszigSchool of Optometry, University of California, Berkeley, California, United States of America.
University of California, Berkeley · USTouro University California · US

Funding

Corneal Infection: Role of Bacterial AdaptationR01EY024060 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI FLEISZIG, SUZANNE MJ · 2014 to 2018
$2.0M
NEI NIH HHS R01 EY024060
6 · The paper itself

Abstract

It is generally thought that mucosal fluids protect underlying epithelial surfaces against opportunistic infection via their antimicrobial activity. However, our published data show that human tear fluid can protect against the major opportunistic pathogen Pseudomonas aeruginosa independently of bacteriostatic activity. Here, we explored the mechanisms for tear protection, focusing on impacts of tear fluid on bacterial virulence factor expression. Results showed that tear fluid suppressed twitching motility, a type of surface-associated movement conferred by pili. Previously, we showed that twitching is critical for P. aeruginosa traversal of corneal epithelia, exit from epithelial cells after internalization, and corneal virulence. Inhibition of twitching by tear fluid was dose-dependent with dilutions to 6.25% retaining activity. Purified lactoferrin, lysozyme, and contrived tears containing these, and many other, tear components lacked the activity. Systematic protein fractionation, mass spectrometry, and immunoprecipitation identified the glycoprotein DMBT1 (Deleted in Malignant Brain Tumors 1) in tear fluid as required. DMBT1 purified from human saliva also inhibited twitching, as well as P. aeruginosa traversal of human corneal epithelial cells in vitro, and reduced disease pathology in a murine model of corneal infection. DMBT1 did not affect PilA expression, nor bacterial intracellular cyclicAMP levels, and suppressed twitching motility of P. aeruginosa chemotaxis mutants (chpB, pilK), and an adenylate cyclase mutant (cyaB). However, dot-immunoblot assays showed purified DMBT1 binding of pili extracted from PAO1 suggesting that twitching inhibition may involve a direct interaction with pili. The latter could affect extension or retraction of pili, their interactions with biotic or abiotic surfaces, or cause their aggregation. Together, the data suggest that DMBT1 inhibition of twitching motility contributes to the mechanisms by which mucosal fluids protect against P. aeruginosa infection. This study also advances our understanding of how mucosal fluids protect against infection, and suggests directions for novel biocompatible strategies to protect our surface epithelia against a major opportunistic pathogen.

Indexed as

Anti-Bacterial AgentsCalcium-Binding ProteinsCells, CulturedCorneaDNA-Binding ProteinsEpithelial CellsEpithelium, CornealGlycoproteinsHumansKeratitisOpportunistic InfectionsPseudomonas aeruginosaPseudomonas InfectionsReceptors, Cell SurfaceTumor Suppressor ProteinsVirulenceAnti-Bacterial AgentsCalcium-Binding ProteinsDMBT1 protein, humanDNA-Binding ProteinsGlycoproteinsReceptors, Cell SurfaceTumor Suppressor ProteinsVirulence Factors

Identifiers

PMID28489917
PMCPMC5440049
OpenAlexW2614009534

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.